Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RPL5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
UBL4A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NDUFAF7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TTL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MMS19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CACUL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FHOD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SORT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TIMM44 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
PLPPR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MEGF6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEPN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD59 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KMT5A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
JAG2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MCEE - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SFTPD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on